Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Exact Sciences Corporation - Common Stock (NQ: EXAS )

55.98 +0.85 (+1.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Exact Sciences Sues Rival Geneoscopy Related To Colon Cancer Test Cologuard Patent
Exact Sciences Corp (NASDAQ: EXAS) filed a patent infringement lawsuit against Geneoscopy in the U.S. 
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
3 Stocks to Love Despite All of the Wall Street Hate
We're in the early stages of a bull market, so the Street hates most smaller companies, but these contrarian stock picks are set to soar. 
Via InvestorPlace
7 Biotech Stocks to Buy for Big-Time Gains
Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript
EXAS earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Analyst Ratings for Exact Sciences
Via Benzinga
7 Analysts Have This to Say About Exact Sciences
Via Benzinga
Where Will Exact Sciences Be in 5 Years?
The company's fight against cancer is only beginning. 
Via The Motley Fool
Exact Sciences, A Cathie Wood Holding, Comes In Hot With Double-Digit Sales Growth
The company makes a diagnostic tool to detect colon cancer. 
Via Investor's Business Daily
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Jim Cramer Wants You To 'Stay Away' From This Energy Corporation: 'I've Got So Many Other Good Oil Companies'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said CVS Health Corporation (NYSE: CVS) is a retailer that has a healthcare business. "It’s not a healthcare business that is a retailer, and retail... 
Via Benzinga
Cathie Wood's Ark Invest Sells $1.9M in Grayscale Bitcoin Fund, Sheds Coinbase Holdings And Shops For $1.8M Worth Of Robinhood Stock
On Tuesday, Cathie Wood-led Ark Invest made significant trades, with a notable purchase of shares in Robinhood Markets Inc (NASDAQ:HOOD) while offloading positions in Coinbase Global Inc (NASDAQ:COIN)... 
Via Benzinga
3 Comeback Stocks to Buy Before They Soar Again in 2024
High Treasury yields were triggered by economic growth, not inflation. As a result, there are likely to be many comeback stocks. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Cathie Wood's Biggest Holdings Are Tumbling, Including Tesla
Even Ark Invest's big 2023 winners are well off highs. 
Via Investor's Business Daily
7 Winning Stocks That Will Make You an Investing Champion
Inflation is under control and economic growth is strong. Here are seven winning stocks to buy to exploit the positive trends. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Cathie Wood’s 3 Favorite AI Stocks: October 2023
Despite the surprising sale of her Nvidia stock, investors can still look to Cathie Wood for guidance on future purchases of AI stocks. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Affordable Stocks to Invest in as America’s Population Ages
Stocks for an aging population include some surprisingly youthful products and firms not commonly associated with seniors. 
Via InvestorPlace
Exact Sciences' Stock Offers A 'Good Entry Point,' This Bullish Analyst Says
Shares of Exact Sciences Corp (NASDAQ: EXAS) were climbing in early trading on Tuesday, ahead of the company’s third-quarter earnings call. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Via Benzinga
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?
The oncology diagnostic companies are looking for better solutions in early cancer diagnosis. 
Via The Motley Fool
2 Cathie Wood Stocks That Could Deliver Exponential Returns
These two cutting-edge healthcare companies could be significantly undervalued right now. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Via Benzinga
2 Cathie Wood Stocks Up by 35% and 70% That Could Make You Richer
You aren't too late to the party. 
Via The Motley Fool
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
The 3 Best Cathie Wood Stocks to Buy Now: September 2023
Most of Cathie Wood's stock picks are not too impressive. Still, a few of them are worth considering. Here are the best Cathie Wood stocks. 
Via InvestorPlace
10 Reasons You May Want To Have Mainz Biomed (NASDAQ: MYNZ) On Your Radar
The WHO reports that colorectal cancer is the second most fatal cancer around the world. 
Via Benzinga
Is Cathie Wood The Next Warren Buffett? Apple, Tesla Define Their Investment Strategies
With a track record of 60-plus years of strong returns for investors, Warren Buffett, who turns 93 Wednesday, is considered one of the all-time 
Via Benzinga
Second Most Fatal Cancer In U.S. May Soon Face A Challenger: Mainz Biomed's (NASDAQ: MYNZ) Early Detection Tech
Colorectal cancer is the third most common cancer worldwide, and although the majority of colorectal cancer cases have historically occurred in individuals aged 45 and older, it is increasingly... 
Via Benzinga
Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.